Princeton Capital Partners

Addus HomeCare Corporation provides a range of social and medical services to individuals. The company serves individuals with special needs who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill, and disabled. It offers various health services that include personal care and assistance with activities of daily living, skilled nursing and rehabilitative therapies, and adult day care.

The company’s Home and Community Services segment offers assistance with bathing, grooming, dressing, personal hygiene and medication reminders, and other activities of daily living on a long-term and continuous basis, with an average duration of approximately 20 months per consumer. Its Home Health Services segment provides physical, occupational, and speech therapy, as well as skilled nursing services, which are offered on a short-term, intermittent, or episodic basis to individuals recovering from an acute medical condition, with an average length of care of approximately 80 days.

The company’s payor clients include federal, state, and local governmental agencies; commercial insurers; and private individuals. It operates through approximately 117 locations across 19 states. Addus HomeCare Corporation was founded in 1979 and is headquartered in Palatine, Illinois.

Advocat Inc., together with its subsidiaries, provides long-term care services to nursing center patients primarily in the southeast and southwest United States. It offers various non-institutional and institutional services, which include skilled nursing, ancillary health care services, and assisted living to the elderly. The company also provides rehabilitative, nutritional, respiratory, and other specialized ancillary services. As of December 31, 2008, Advocat operated 50 nursing centers consisting of 5,773 licensed nursing beds and 14 assisted living units. It has nursing centers in Alabama, Arkansas, Florida, Kentucky, Ohio, Tennessee, Texas, and West Virginia. The company was founded in 1994 and is based in Brentwood, Tennessee.

Allied Healthcare International Inc., together with its subsidiaries, provides flexible or temporary healthcare staffing services to the healthcare and social care industries in the United Kingdom. Its healthcare staff primarily includes homecare aides, nurses, and nurses’ aides. The company provides healthcare staffing services to local governmental social service departments; government-funded National Health Service (NHS), which operates hospitals through NHS Acute Trusts and Foundation Trusts; private individuals; independent hospitals; and nursing and care homes. As of September 30, 2009, Allied Healthcare International operated an integrated network of approximately 100 branches. The company, formerly known as Transworld Healthcare, Inc., was founded in 1981 and is headquartered in New York, New York.

ACQUIRED

Almost Family, Inc. provides home health services in the United States. It operates in two segments, Visiting Nurse Services and Personal Care Services.

The Visiting Nurse Services segment provides a range of Medicare-certified home health nursing services to patients in need of recuperative care, as well as services to patients in lieu of additional care in other settings, such as long term acute care hospitals, inpatient rehabilitation hospitals, or skilled nursing facilities. This segment also offers special clinically-based protocols, including frail elderly care management, optimum balance, silver steps, cardiocare, orthopedic, and urology programs to medically complex, chronic, and co-morbid patient populations.

The Personal Care Services segment provides personal care, medication management, meal preparation, caregiver respite, and homemaking services in patients’ homes primarily on an as-needed, hourly basis.

The company offers services through its service locations in Florida, Ohio, Kentucky, Connecticut, New Jersey, Massachusetts, Missouri, Indiana, Illinois, Pennsylvania, Tennessee, Georgia, Mississippi, and Alabama. It operates approximately 86 Medicare-certified home health agencies with 175 locations; and 66 personal care locations. Almost Family, Inc. was founded in 1976 and is based in Louisville, Kentucky

ACQUIRED

AMICAS, Inc. is a leader in radiology and medical image and information management solutions. The AMICAS ONE Suite™ provides a complete, end-to-end solution for imaging centers, ambulatory care facilities, and radiology practices. Acute care and hospital clients are provided with a fully-integrated, HIS/RIS-independent PACS, featuring advanced enterprise workflow support and scalable design.

Complementing the AMICAS radiology automation solutions is AMICAS Professional Services™, a set of client- centered professional and consulting services that assist our customers with a well-planned transition to a digital enterprise.

ACQUIRED

AngioDynamics, Inc. designs, develops, manufactures, and markets various therapeutic and diagnostic devices that enable interventional physicians to treat PVD, tumors, and other non-coronary diseases. The company operates in two divisions, Vascular and Oncology/Surgery.

The Vascular division provides venous products, including VenaCure EVLT laser systems and Sotradecol; angiographic products and accessories comprising angiographic catheters, entry needles, guidewires, and fluid management products; percutaneous transluminal angioplasty dilation balloon catheters, such as WorkHorse, WorkHorse II, and Profiler to open blocked blood vessels and dialysis access sites; drainage products consisting of the total abscession general, biliary, and nephrostomy drainage catheters; and thrombolytic products that include pulsespray infusion and unifuse thrombolytic catheters, and speedlyser to deliver thrombolytic agents.

It also offers micro access sets that provide interventional physicians a smaller introducer system for minimally-invasive procedures; Benephit, a therapeutic approach to deliver drugs directly to the kidneys; and various dialysis catheters, which comprise DuraMax, Schon, Evenmore, Dura-Flow, SCHON XL, LifeJet, and Centros dialysis catheters. In addition, this division provides PICC products consisting of Morpheus CT PICC, Morpheus CT PICC insertion kits, and Morpheus smart PICC; port products and accessories, including Vortex, SmartPort, and LifeGuard; and central venous catheter products.

The Oncology/Surgery division offers radiofrequency ablation, embolization, and nanoknife products. The company markets its products to interventional radiologists, vascular surgeons, and surgical oncologists through a direct sales force in the United States and through a combination of direct sales and distributor relationships internationally. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

Brookdale Senior Living Inc. owns and operates senior living communities in the United States. It operates through five segments: Retirement Centers, Assisted Living, CCRCs, Brookdale Ancillary Services, and Management Services. The Retirement Centers segment owns or leases communities comprising independent living and assisted living units in a single community that are primarily designed for middle to upper income senior citizens. The Assisted Living segment owns or leases communities consisting of freestanding, multi-story communities, and freestanding single story communities, which offer housing and 24-hour assistance with activities of daily life to mid-acuity frail and elderly residents. This segment also operates memory care communities for residents with Alzheimer’s disease and other dementias. The CCRCs - Rental segment owns or leases communities that offer various living arrangements and services to accommodate various levels of physical ability and health. The Brookdale Ancillary Services segment provides outpatient therapy, home health, and hospice services; and education and wellness programs to residents of its communities, as well as to other senior living communities. The Management Services segment operates communities under the management agreements. As of December 31, 2017, the company operated 129 retirement center communities with 24,476 units; 822 assisted living communities with 56,718 units; and 72 CCRCs with 19,388 units, as well as owned or leased 794 communities with 66,641 units and provided management services with respect to 229 communities with 33,941 units for third parties or unconsolidated ventures. Brookdale Senior Living Inc. is headquartered in Brentwood, Tennessee.

Candela Corporation engages in the development and commercialization of aesthetic laser and light-based systems that allow physicians and personal care practitioners to treat various cosmetic and medical conditions worldwide. The company’s product line includes GentleMax, an aesthetic treatment workstation; AlexTriVantage for the treatment of pigmented lesion and tattoo colors removal; SmoothPeel for laser peels; and Serenity Pro-Revolutionary Pneumatic Skin Flattening technology for pain reduction in laser and intense pulse light treatments. It also provides GentleLASE family of lasers for the treatment of permanent hair reduction, vascular lesions, wrinkle reduction, and treatment of pigmented lesion; GentleYAG family of lasers, which provide permanent hair reduction for skin type, including tanned or dark skin, treatment of beard bumps, leg and facial veins, and skin tightening; Vbeam, which eliminates vascular lesions including port wine stain birthmarks, rosacea, leg and facial veins, and provides skin rejuvenation by the reduction of diffuse redness and pigmentation, scars, warts, psoriasis, and hemangiomas; and Smoothbeam diode laser for treatment of acne and acne scars, sebaceous hyperplasia, and wrinkle reduction. It markets its products directly and through a network of distributors to plastic surgeons and dermatologists, general practitioners, family care practitioners, obstetricians and gynecologists, and general and vascular surgeons. The company was founded in 1969 and is headquartered in Wayland, Massachusetts.

ACQUIRED

Capital Senior Living Corporation, together with its subsidiaries, owns, operates, develops, and manages senior housing communities in the United States. The company provides senior living services to the elderly, including independent living, assisted living, and home care services. Its independent living services include daily meals, transportation, social and recreational activities, laundry, housekeeping, and 24-hour staffing; and access to health screenings, periodic special services, dietary and similar programs, and ongoing exercise and fitness classes.

The company’’s assisted living services comprise personal care services, such as assistance with activities of daily living comprising ambulation, bathing, dressing, eating, grooming, personal hygiene, and monitoring or assistance with medications; support services, including meals, assistance with social and recreational activities, laundry, general housekeeping, maintenance, and transportation services; and supplemental services comprising extra transportation services, personal maintenance, extra laundry services, and special care services for residents with certain forms of dementia. In addition, it offers home care services through its home care agency.

As of December 31, 2016, the company operated 129 senior housing communities in 23 states with an aggregate capacity of approximately 16,500 residents, including 79 owned senior housing communities and 50 leased senior housing communities, as well as 1 home care agency. Capital Senior Living Corporation was founded in 1990 and is headquartered in Dallas, Texas.

CardioNet, Inc. (BEAT) provides ambulatory, continuous, and real-time outpatient management solutions for monitoring relevant and timely clinical information regarding an individual’s health in the United States. It focuses on diagnosing and monitoring cardiac arrhythmias or heart rhythm disorders. The company offers Mobile Cardiac Outpatient Telemetry (MCOT) device that incorporates a patient-worn sensor attached to leads, which captures electrocardiogram (ECG) data and communicates wirelessly with a compact monitor that analyzes incoming information by applying proprietary algorithms designed to detect arrhythmias and eliminate data noise. Its MCOT device automatically transmits the ECG data to the CardioNet Monitoring Center, when the monitor detects an arrhythmic event. The company also provides event monitoring services to record and store approximately 540 seconds of ECG signal; Holter monitoring services that store an image of the electrical impulses of every heartbeat or irregularity in either digital format on an internal compact flashcard or in analog format on a standard cassette tape located inside the monitor. In addition, it offers pacemaker monitoring services. The company markets its arrhythmia monitoring solutions, including the MCOT, primarily to cardiologists and electrophysiologists. CardioNet, Inc. has a strategic alliance with MedApps, Inc. The company was incorporated in 1994 and is headquartered in Conshohocken, Pennsylvania.

CareDx, Inc., a transplant diagnostics company, together with its subsidiaries, engages in the discovery, development, and commercialization of diagnostic surveillance solutions for transplant patients worldwide. It operates through two segments, Post-Transplant Diagnostics and Pre-Transplant Diagnostics. The Post-Transplant Diagnostics segment develops and provides a diagnostic surveillance testing solution for heart and kidney transplant recipients. It offers AlloMap, a heart transplant molecular test; and AlloSure, a donor-derived cell free DNA test initially used for kidney transplant patients. The Pre-Transplant Diagnostics segment develops, manufactures, markets, and sells products that increase the chance of successful transplants by facilitating a match between a donor and a recipient of stem cells and organs. It sells Olerup SSP, which is used to type human leukocyte antigen (HAL) alleles based on sequence-specific primer technology; Olerup QTYPE, a test kit for sequence based HLA typing; Olerup SBT, a test kit for sequence based HLA typing; and XM-ONE, a test that identifies a patient’s antigens against HLA Class I or Class II, as well as antibodies against a donor’s endothelium. This segment offers its products directly to customers, as well as through third-party distributors. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. CareDx, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.

ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. In addition, it offers continence and critical care products, including intermittent urinary catheters; and products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other urological disorders, as well as devices and products used in intensive care units and hospital settings. Further, the company provides advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and various disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, suction handles and tubes, gastroenterology tubes, and securement devices. Additionally, it offers disposable infusion sets to manufacturers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and various products to hospital and home healthcare markets. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 1978 and is headquartered in Reading, the United Kingdom.

Cross Country Healthcare, Inc. provides healthcare staffing and workforce solutions in the United States. The company operates through three segments: Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services.

The Nurse and Allied Staffing segment provides traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, and branch based local nurses and allied staffing; and short-term staffing of registered nurses, licensed practical nurses, and nurse assistants on short-term assignments. This segment markets its nurse and allied staffing services under the Cross Country Staffing and Allied Health Group brands; and provides health and medical services for-profit and not-for-profit sectors. It serves public and private acute-care and non-acute care hospitals, government facilities, schools, outpatient clinics, ambulatory care facilities, physician practice groups, retailers, and other healthcare providers.

The Physician Staffing segment provides temporary physician staffing (locum tenens) services to the healthcare industry. This segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants under the Medical Doctor Associates brand as independent contractors on temporary assignments at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations.

The Other Human Capital Management Services segment offers education and training programs, as well as provides retained search services for physicians and healthcare executives. Cross Country Healthcare, Inc. was founded in 1996 and is headquartered in Boca Raton, Florida.

Cutera, Inc., a medical device company, engages in designing, developing, manufacturing, marketing, and servicing laser and other light-based aesthetics systems for practitioners worldwide. It offers products based on three platforms: CoolGlide, Xeo, and Solera, which enable physicians and other qualified practitioners to perform aesthetic procedures. The CoolGlide product platform offers laser applications for hair removal; the treatment of a range of vascular lesions, including leg and facial veins; and Laser Genesis, a skin rejuvenation procedure that reduces fine lines and pore size, and improves skin texture. The Xeo platform can combine pulsed light and laser applications in a single system, as well as enables customers in removing unwanted hair, treating vascular lesions, and rejuvenating the skin by treating discoloration, improving texture, reducing pore size, and treating fine lines and laxity. The Solera platform is a compact tabletop system to support a single technology platform that uses infrared (Solera Titan) or pulsed light (Solera Opus), which is used to remove unwanted hair, treat vascular lesions, and rejuvenate the skin. The company sells its products through direct sales force and distributors to dermatologists, plastic surgeons, gynecologists, family practitioners, primary care physicians, physicians offering aesthetic treatments in non-medical offices, and other qualified practitioners. It has a strategic alliance with Sound Surgical Technologies, LLC to distribute their VASER Lipo System in Europe and Canada. The company was founded in 1998 and is headquartered in Brisbane, California.

Derma Sciences, Inc. operates as a tissue regeneration company in the wound care market. Its Advanced Wound Care segment offers MEDIHONEY dressings for managing non-chronic and hard-to-heal wounds, including chronic ulcers, burns, and post-operative wounds; TCC-EZ system for patients with diabetic foot ulcers; AMNIOEXCEL for tissue repair, reconstruction, and replacement; and AMNIOMATRIX that is used as a wound covering in the treatment of localized tissue defects. This segment also provides XTRASORB dressings, which convert fluid within the dressings to a gel and lock the exudates into the dressings; BIOGUARD dressings for prophylactic use in the prevention of hospital or community acquired infections through wound sites; ALGICELL AG antimicrobial dressings; and occlusive dressings, such as hydrocolloids, foams, hydrogels, alginates, additional silver antimicrobial dressings, cleansers, and DERMAGRAN products.

The company’s Traditional Wound Care segment offers gauze sponges and bandages, non-adherent impregnated dressings, retention devices, paste bandages, and other compression devices; adhesive bandages and related first aid products; private-label wound care products; wound closure strips, nasal tube fasteners, and catheter fasteners; and general purpose and specialized skin care products.

Its Pharmaceutical Wound Care segment develops DSC127, an angiotensin analog that is in Phase III clinical trials for the treatment of diabetic foot ulcers, and preclinical testing for scar reduction. The company sells its products to various health care providers, including wound care centers, extended care facilities, acute care facilities, home health care agencies, physicians’ offices, nursing homes, hospitals, and clinics through direct sales and manufacturers’ representatives, independent distributors, and retail channels in the United States, Canada, and the United Kingdom. Derma Sciences, Inc. was founded in 1984 and is headquartered in Princeton, New Jersey.

ACQUIRED

Digirad Corporation provides diagnostic imaging products, and personnel and equipment leasing services primarily in the United States. The company operates in two segments, Digirad Imaging Solutions and Product. The Digirad Imaging Solutions segment offers various personnel and equipment leasing services for physicians to perform nuclear imaging, echocardiography, vascular ultrasound, or any combination of these procedures in their offices by leasing the imaging system, certified personnel, and other support required to perform imaging. This segment primarily serves cardiologists and internists. The Product segment manufactures and sells solid-state gamma cameras and accessories for general nuclear imaging and specific clinical-application imaging, as well as offers camera maintenance services. This segment sells its imaging systems to physician offices, hospitals, and imaging centers. The company was founded in 1985 and is headquartered in Poway, California.

Diversicare Healthcare Services Inc., together with its subsidiaries, provides long-term care services to nursing center patients primarily in the Southeast and Southwest United States. The company offers skilled nursing health care services, including room and board, nutrition services, recreational therapy, social services, housekeeping, and laundry services; rehabilitation therapy services, such as audiology, speech, occupational, and physical therapies; and medical supplies, nutritional support, infusion therapies, and related clinical services.

As of May 1, 2013, it operated 53 nursing centers with 5,982 licensed nursing beds. The company was formerly known as Advocat Inc. and changed its name to Diversicare Healthcare Services Inc. in March 2013. Diversicare Healthcare Services Inc. was founded in 1994 and is based in Brentwood, Tennessee.

ACQUIRED

Epocrates, Inc. provides subscriptions for mobile drug reference tools and electronic health records to healthcare professionals, and interactive services to the healthcare industry. The company offers Epocrates mobile physician platform, which provides access to information that healthcare professionals need at the point of care, such as dosing, drug interactions, pricing, and insurance coverage for various brands, and generic and over-the-counter drugs; and Epocrates online drug and clinical reference products, which comprise drug and formulary information, access to disease content, and patient education handouts, as well as alternative medicine database, various medical equations, clinical criteria, and unit/dose converters.

It also provides interactive services, such as DocAlert clinical messaging to deliver news and alerts, including product approvals, clinical study results, practice management information, industry guidelines, and formulary status changes to the users; market research programs to survey healthcare professionals; formulary hosting services; and mobile resource center, an educational service that provides information on clinical developments for various diseases, conditions, and topics.

In addition, the company offers virtual representative services, including drug detailing, drug sampling, patient literature delivery, and the ability to contact drug manufacturers at the point of care; Epocrates’ Essential Points, which enable pharmaceutical clients to sponsor activities on relevant topics and communicates through overviews on physicians’ mobile devices; and Epocrates’ App Network, a service that enables development, distribution, or sponsorship of apps, which are offered to targeted groups of physicians in the network.

Epocrates, Inc. was incorporated in 1998 and is based in San Mateo, California.

Epocartes Inc. has been acquired.

ACQUIRED

Five Star Quality Care, Inc. operates senior living communities, including independent living or congregate care communities, assisted living communities, and nursing facilities in the United States. The company provides independent living, assisted living, nursing and healthcare, physical therapy, occupational therapy, speech language pathology, onsite pharmacy, radiology, laboratory, telemetry, hemodialysis, and orthotics/prosthetics services. As of December 31, 2008, the company leased, owned, and operated 210 senior living communities with 49 skilled nursing facilities with 4,410 units. The company also operated institutional pharmacies, 2 rehabilitation hospitals, and 15 outpatient clinics. Five Star Quality Care, Inc. was founded in 2000 and is based in Newton, Massachusetts.

Global Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.

Harvard Bioscience, Inc. develops, manufactures, and markets scientific instruments, systems, and lab consumables used in life science research. The company offers cell and animal physiology products, such as syringe pump and peristaltic pump products, as well as a range of instruments and accessories, including surgical products, infusion systems, microdialysis instruments, behavior research systems, isolated organ and tissue bath systems, and in vivo and in vitro electrophysiology recording, stimulation and analysis systems for tissue, organ, and animal based lab research under the Harvard Apparatus, CMA Microdialysis, Panlab, Coulbourn, Hugo-Sachs, InBreath Bioreactor, MCS, TBSI, and HEKA brands. It also provides products for molecular biology labs comprising pipettes and pipette tips, gloves, gel electrophoresis equipment and reagents, autoradiography films, thermal cycler accessories and reagents, sample preparation columns, tissue culture products, and general lab equipment and consumables under the Denville Scientific, AHN, and other brands. In addition, the company offers spectrophotometers under the Libra, WPA, and BioDrop brands; microplate readers; amino acid analyzers; gel electrophoresis equipment under the Hoefer and Scie-Plas brands; and electroporation and electrofusion products, including systems and generators, electrodes, and accessories for research applications, such as in vivo, and in vitro gene delivery, cell fusion, and nuclear transfer cloning under the Harvard Apparatus BTX brand. Harvard Bioscience, Inc. markets its products to research scientists at universities, hospitals, government laboratories, and pharmaceutical and biotechnology companies. The company sells its products in approximately 100 countries through Websites, catalogs, and distributors. Harvard Bioscience, Inc. was founded in 1901 and is headquartered in Holliston, Massachusetts.

Healthcare Services Group, Inc. provides management, administrative, and operating services to the housekeeping, laundry, linen, facility maintenance, and dietary service departments of nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States. It operates through two segments, Housekeeping and Dietary. The Housekeeping segment engages in the cleaning, disinfecting, and sanitizing of resident rooms and common areas of the customers’ facilities, as well as laundering and processing of the bed linens, uniforms, resident personal clothing, and other assorted linen items utilized at the customers’ facilities. The Dietary segment provides food purchasing, meal preparation, and professional dietitian services, which include the development of menus that meet the dietary needs of residents. This segment also offers on-site management and clinical consulting services to facilities. Healthcare Services Group, Inc. was incorporated in 1976 and is based in Bensalem, Pennsylvania.

HMS Holdings Corp., through its subsidiaries, provides healthcare insurance benefit cost containment services in the United States. The company’s coordination of benefits services provide cost avoidance services that offer validated insurance coverage information, which is used by government-sponsored payers to coordinate benefits for incoming claims; payment integrity services to identify improper payments on a pre-payment and post-payment basis, identify and recover overpayments, detect and prevent fraud and abuse, and identify process improvements; and eligibility verification services comprising asset and income verification, premium assistance, dependent eligibility audits, and other verification solutions.

HMS Holdings Corp. serves state Medicaid agencies; the centers for Medicare and Medicaid services; commercial health plans, including Medicaid managed care, Medicare Advantage, and group health lines of business; government and private employers; child support agencies; the Veterans Health Administration; and other healthcare payers and sponsors. HMS Holdings Corp. was founded in 1974 and is headquartered in Irving, Texas.

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. The company offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. It also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. In addition, the company offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system that delivers laser to treat glaucoma; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. It serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. IRIDEX Corporation markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was founded in 1989 and is headquartered in Mountain View, California.

Kindred Healthcare, Inc. provides healthcare services in the United States. It operates in four divisions: Hospital, Nursing Center, Rehabilitation, and Care Management.

The Hospital division operates transitional care hospitals that provide services for medically complex patients, including the critically ill, suffering from multiple organ system failures, primarily the cardiovascular, pulmonary, kidney, gastro-intestinal, and cutaneous systems. This division also operates inpatient rehabilitation hospitals, which offer services to patients who require intensive inpatient rehabilitative care.

The Nursing Center division operates nursing centers and assisted living facilities that provide short stay patients and long stay residents with a range of medical, nursing, rehabilitative, pharmacy, and routine services, including daily dietary, social, and recreational services.

The Rehabilitation division provides rehabilitation services, including physical and occupational therapies, and speech pathology services to residents and patients of nursing centers, acute and long-term acute care hospitals, outpatient clinics, home health agencies, assisted living facilities, school districts, and hospice providers under the RehabCare name.

The Care Management division provides home health, hospice, and private duty services to patients in various settings, including homes, skilled nursing facilities, and other residential settings under the Kindred at Home name.

As of December 31, 2014, Kindred Healthcare, Inc. provided healthcare services in 2,872 locations, including 97 transitional care hospitals, 16 inpatient rehabilitation hospitals, 90 nursing centers, 22 sub-acute units, and 100 inpatient rehabilitation units; and 634 Kindred at Home hospice, home health, and non-medical home care locations, as well as a contract rehabilitation services business, which served, 1,913 non-affiliated facilities. The company is headquartered in Louisville, Kentucky.

ACQUIRED

LifeWatch AG (SIX Swiss Exchange: LIFE), headquartered in Neuhausen am Rheinfall, Switzerland, is a leading company for healthcare technologies and solutions, specializing in advanced telehealth systems and wireless cardiac monitoring services for high-risk and chronically ill patients, including ordinary consumers of health products and those who are worried about their wellness. LifeWatch’s strategy is to become the global leader in developing & providing state-of-the-art technologies and services for personal well being through the development of innovative and cost-effective solutions for real time detection, diagnosis and monitoring of personal well-being. LifeWatch’s newest wireless healthcare system, the PMP4, provides the tools required for screening, monitoring, and the management of General Consumer Health, Disease management and Wellness and Fitness. LifeWatch manufactures a line of traditional products for the telehealth market, including 1 to 12-lead ECG event recorders, looping recorders, a diagnostic 12-lead ECG, Spirophone, Fetal Maternal Monitors, and telemedicine software packages.

ACQUIRED

Lumenis Ltd, together with its subsidiaries, develops and commercializes energy-based medical systems. The company operates in three segments: Surgical, Ophthalmic, and Aesthetic.

The Surgical segment offers various surgical laser systems and accessories used for urology/genitourinary and ENT to hospitals, outpatient clinics, ambulatory surgery centers, and medical practices.

The Ophthalmic segment sells ophthalmology laser systems and accessories, such as laser links, slit lamp microscopes, laser indirect ophthalmoscopes, physician eye safety filters, surgical laser probes, and others to ophthalmic practices, outpatient clinics, and ophthalmology departments of hospitals, primarily for use in retinal treatment and glaucoma/secondary cataract applications, as well as for refractive applications.

The Aesthetic segment offers aesthetic laser energy-based systems to physicians, primarily for skin treatment and hair removal applications. The company also provides technical training and certification of field service engineers and distributor service personnel; operates communications centers that perform installation, maintenance, and periodic and preventive servicing activities; publishes and controls the technical documentation, including service manuals and technical bulletins; and provides spare parts and logistics channels.

It markets its products through a network of third-party distributors, direct sales force, and independent distributors in the Americas, Japan, the Asia pacific, Europe, the Middle East, and Africa. The company was formerly known as ESC Medical Systems Ltd. and changed its name to Lumenis Ltd. in September 2001. Lumenis Ltd. was founded in 1991 and is headquartered in Yokneam, Israel.

ACQUIRED

MEDNAX, Inc., together with its subsidiaries, provides newborn, anesthesia, maternal-fetal, radiology and teleradiology, pediatric cardiology, and other pediatric subspecialty physician services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; anesthesia and anesthesia subspecialty care services; and acute and chronic pain management services. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and their unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, and pediatric surgeons, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of October 31, 2019, it had a network of approximately 4,250 physicians. The company was founded in 1979 and is based in Sunrise, Florida.

Medquist Inc (MEDQ) integrates dictation capture, workflow management, speech recognition, medical transcription, and document distribution. Its maintenance services include onsite maintenance and remote ‘break-fix’ services, as well as application, hardware, and software technical support for its products. In addition, the company offers SpeechQ for Radiology, a front-end speech recognition software application that allows radiologists to dictate, edit, and sign their reports in a single session or send them to an editor following dictation; and DocQvoice, a Web-based enterprise digital voice capture and transport solution. It serves health systems, hospitals, and large group medical practices. The company was founded in 1984 and is headquartered in Mount Laurel, New Jersey. MedQuist Inc. operates as a subsidiary of CBaySystems Holdings Limited.

ACQUIRED

Merge Healthcare Incorporated develops software solutions that facilitate the sharing of images to create an electronic healthcare experience for patients and physicians worldwide. It operates in two segments, Merge Healthcare and Merge DNA.

The company offers iConnect, an image interoperability and connectivity platform that enables hospitals, imaging centers, integrated delivery networks, and health information exchanges to create information exchanges within their environments and with other entities. It also provides clinical and financial information systems that include picture archiving and communication systems (PICS) for general image review and management; specialty solutions for cardiology, orthopaedics, ophthalmology, mammography, and oncology; add-on modules, such as referring physician portals and critical test results reporting; eFilm workstation for general radiology reading; CADstream workstations for specialty reading of magnetic resonance imaging; clinical information systems that provide an electronic record of a medical procedure in various specialties; and software and services for the revenue cycle management of physician practices.

In addition, the company provides software development toolkits, technologies, and platforms for original equipment manufacturers, medical device manufacturers, and RIS/PICS or general healthcare IT vendors to assist in development of new products and enhancement of existing products. Further, it offers hosted software solutions, including electronic data capture, interactive voice/Web response, and electronic patient reported outcomes software and devices to pharmaceutical companies, contract research organizations, or imaging core labs for the collection, aggregation, analysis, reporting, and overall management of clinical trials information.

Merge Healthcare Incorporated was founded in 1987 and is headquartered in Chicago, Illinois.

ACQUIRED

MGC Diagnostics Corporation designs and markets non-invasive cardio respiratory diagnostic systems under the MedGraphics and New Leaf brand names in the United States and internationally.

The company’s primary products include pulmonary function and cardiopulmonary exercise testing systems. Its pulmonary function systems comprise Spirometry, Complete Pulmonary Function, and Body Plethysmography product categories, which enable the early detection of lung disease; evaluate the effect of medication; monitor patients with chronic disease; diagnose lung diseases, such as asthma, emphysema, and chronic obstructive pulmonary disease; manage treatment; assess the surgical risk of lung transplant and lung reduction candidates; and evaluate the impact of neuromuscular disease on breathing.

The company’s cardiopulmonary exercise testing systems measure functional capacity, fitness, or conditioning levels, and evaluate prognostic criteria for surgical procedures, as well as help physicians diagnose heart and lung diseases. Its cardiopulmonary exercise testing systems find applications in distinguishing between cardiovascular and pulmonary disease, screening for early signs of cardiac and pulmonary dysfunction, establishing exercise prescriptions and training programs, evaluating the efficacy of prescribed therapy, and determining appropriate nutritional supports requirements. The company also offers cycle ergometers and treadmills for use in diagnostic, rehabilitation, training, and sports medicine applications; and BreezeConnect software, installation, and support for communications interfaces.

It serves hospitals, university-based medical centers, medical clinics, physician offices, health and fitness clubs, weight loss clinics, and personal training studios. The company was formerly known as Angeion Corporation and changed its name to MGC Diagnostics Corporation in August 2012. MGC Diagnostics Corporation was founded in 1986 and is based in Saint Paul, Minnesota.

ACQUIRED

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts. The company’s patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a semi-permeable protective barrier membrane product used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, pressure ulcers, and burns; AmnioFix, a semi-permeable protective barrier membrane product for the treatment of wounds related to surgical procedures; EpiCord and AmnioCord that are dehydrated human umbilical cord allografts intended for homologous applications; and AmnioFill that consists of particles of connective tissue matrix derived from placental disc and placental membranes. The company’s products have applications primarily in the areas of wound care, burn, surgical, and non-operative sports medicine sectors of healthcare. It also sells allografts for dental applications on an original equipment manufacturer basis. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. is headquartered in Marietta, Georgia.

New Senior Investment Group (NYSE: SNR) is a publicly-traded real estate investment trust with a diversified portfolio of senior housing properties located across the United States. As of September 30, 2018, New Senior is one of the largest owners of senior housing properties, with 133 properties across 37 states.

ACQUIRED

NightHawk Radiology Holdings, Inc., together with its subsidiaries, provides professional services, business offers professional services that include preliminary reads from images generated from hospital emergency departments, used by the treating physician to determine whether any immediate action is required in response to symptoms being presented by a patient; and final and sub-specialty interpretations, including final emergent exams that provide customers with access to sub-specialty-trained radiologists. It also provides business services, including revenue cycle management, facilities and human resources management, transcription, information technology, quality control, radiologist support, and other services required to operate a radiology practice. In addition, NightHawk Radiology Holdings offers cardiac 3D reconstructions and radiology clinical workflow technology. The company provides its services primarily through direct sales force comprising telesales and field sales personnel. As of December 31, 2009, it provided professional radiology services to approximately 800 radiology practices serving approximately 1,500 hospitals. NightHawk Radiology Holdings was founded in 2001 and is headquartered in Scottsdale, Arizona.

ACQUIRED

Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company’s advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokines, and ECM proteins in the native tissue are preserved; Novachor, a chorion membrane wound covering in which viable cells, growth factors/cytokines, and ECM proteins are preserved; Apligraf, a bioengineered living cell therapy that produce spectrum of cytokines and growth factors; Dermagraft, a bioengineered product that produces human collagen, ECM, proteins, and cytokines; NuShield, a wound covering amnion and chorion membranes for spongy/intermediate layer intact; and PuraPly, a antimicrobial barrier that enables conformability and fluid drainage. Its products also include FortiShield, a biosynthetic wound matrix for use as a temporary wound covering; and FiberOS and OCMP used as a bone void filler primarily in orthopedic and neurosurgical applications. The company’s pipeline products include PuraPly AM, PuraPly XT, and PuraPly MZ to treat chronic, acute, and open wounds; PuraForce, a bioengineered porcine collagen surgical matrix for use in soft tissue reinforcement applications; and TransCyte, a bioengineered tissue for the treatment of partial thickness burns. It serves hospitals, wound care centers, government facilities, ambulatory service centers, and physician office through direct sales representives and independent agencies. The company was founded in 1985 and is headquartered in Canton, Massachusetts.

Orthofix Medical Inc. operates spine and orthopedics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through Global Spine and Global Orthopedics segments. The Global Spine segment comprises the bone growth therapies products, which manufactures and distributes bone growth stimulator devices for enhance of bone fusion including adjunctive and noninvasive treatment of cervical and lumbar spine as well as a therapeutic treatment for non-spine; the spinal implants products designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and the biological products, such as regenerative products and tissue forms which allow physicians to treat a variety of spinal and orthopedic conditions. Global Orthopedics segment offers products and solutions that allow physicians to treat a variety of orthopedic conditions unrelated to the spine, which design, develop, and market the orthopedic products used in fracture repair, deformity correction, and bone reconstruction procedures. It sells its products through distributors, sales representatives, hospitals, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1987 and is headquartered in Lewisville, Texas.

The Providence Service Corporation provides and manages government sponsored social services and non-emergency transportation services. It offers home and community based counseling services, which include home based and intensive home based counseling, substance abuse treatment services, school support services, correctional services, and workforce development; and foster care and therapeutic foster care services.

The company also provides not-for-profit managed services comprising administrative support, information technology, and accounting and payroll services; intake, assessment, and referral services; monitoring services; and case management services.

In addition, the company provides non-emergency transportation management services to state Medicaid programs, local government agencies, hospital systems, health maintenance organizations, private managed care organizations, and commercial insurers, as well as to individuals with limited mobility, people with limited means of transportation, people with disabilities, and Medicaid members. Further, it offers school transportation services to school children, including special needs students who are physically fragile or mentally ill.

The company has operations primarily in the District of Columbia, United States; and British Columbia, Canada. The Providence Service Corporation was founded in 1996 and is headquartered in Tucson, Arizona.

RTI Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and distributes orthopedic and other surgical implants for use in various surgical procedures worldwide. The company provides natural tissue implants, as well as metal and synthetic implants for the treatment of spinal and other orthopedic disorders. It processes donated human musculoskeletal and other tissues, including bone, cartilage, tendons, ligaments, fascia lata, pericardium, sclera, cornea, and dermal tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes. The company’s implants are used in the fields of spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic, surgical specialties, and dental. RTI Surgical, Inc. markets its products through its direct distribution force, as well as through a network of independent distributors to hospitals and surgeons. The company was formerly known as RTI Biologics, Inc. and changed its name to RTI Surgical, Inc. in July 2013. RTI Surgical, Inc. was founded in 1997 and is headquartered in Alachua, Florida.

SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and Internationally. It provides orthobiologics and spinal fusion hardware solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. The company’s orthobiologics products include demineralized bone matrices, collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to enhance bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures. Its spinal fusion hardware products comprise products for spinal fusion in minimally invasive surgery, complex spine, deformity, and degenerative procedures throughout the lumbar, thoracic, and cervical regions of the spine. The company was incorporated in 2015 and is headquartered in Carlsbad, California.

ACQUIRED

Senior Housing Properties Trust, a real estate investment trust (REIT), primarily invests in senior housing properties in the United States. The trust invests in hospitals, nursing homes, senior apartments, independent living properties, and assisted living properties.

As of September 30, 2005, it owned 184 properties, including 85 assisted living facilities, 61 skilled nursing facilities, 36 independent living communities, and 2 hospitals. The trust elected to be taxed as a REIT under Sections 856 through 860 of the Internal Revenue Code. As a REIT, it would not be subject to federal income tax, if it distributes at least 90% of its REIT taxable income to its shareholders.

Senior Housing Properties Trust was organized in 1998 and is based in Newton, Massachusetts.

Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, OPUS, Dermaspan, Softspan, and BIOCORNEUM brand names. It also provides body contouring products; facial and nasal implants; saline filled breast implant sizers; and miraDry System, a non-surgical device for the permanent reduction of underarm sweat, odor, and hair of all colors. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California.

Solta Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets energy-based medical device systems for aesthetic applications primarily in North America, the Asia Pacific, Europe, and the Middle East.

It offers Fraxel repair system for use in dermatological procedures requiring ablation, coagulation, and resurfacing of soft tissue, as well as for rhytides, pigmentation, dyschromia, fine lines, acne, surgical scars, deeper lines, wrinkles, and actinic keratoses; and Clear + Brilliant system, a treatment to improve skin texture and help prevent the signs of aging skin.

The company also provides Thermage CPT system that provides non-invasive treatment options using radiofrequency energy for skin tightening; Liposonix system to destroy unwanted fat cells resulting in waist circumference reduction; a collection of surgical and non-surgical body shaping products; Isolaz system for the treatment of inflammatory acne, comedonal acne, and mild to moderate inflammatory acne; and the CLARO device, a consumer handheld device for the treatment of mild-to-moderate inflammatory acne, including pustular acne. Its customers consist primarily of dermatologists, plastic surgeons, general and family practitioners, gynecologists, ophthalmologists, and others.

The company sells its products through direct sales force and independent distributors; and CLARO device through retail and associated retailer’s Websites, television retail networks, and owned Website in the United States. The company was formerly known as Thermage, Inc. and changed its name to Solta Medical, Inc. in January 2009. Solta Medical, Inc. was incorporated in 1996 and is headquartered in Hayward, California.

ACQUIRED

The Spectranetics Corporation designs, manufactures, and markets single use medical devices used in minimally invasive surgical procedures within the cardiovascular system in conjunction with its proprietary excimer laser system, the CVX-300. The company’s excimer laser technology is used to ablate, or remove, multiple lesion morphology morphologies, including plaque, moderate calcium, and thrombus. It offers four primary product categories for the Vascular Intervention product line, including peripheral atherectomy, coronary atherectomy, thrombus management, and crossing solutions. The peripheral atherectomy product line consists of a selection of proprietary laser catheters that are indicated for above-the-knee and below-the-knee treatments; and the coronary atherectomy product line includes a selection of proprietary laser catheters to be used in various types of coronary artery diseases comprising occluded saphenous vein bypass grafts, ostial lesions, long lesions, moderately calcified stenoses, total occlusions traversable by guidewire, and restenosis. The thrombus management product line consists of three thrombus removal devices intended to remove fresh, soft thrombi, and emboli from vessels in the arterial system, as well as to address thrombotic occlusions in dialysis grafts and fistulae; and the crossing solutions product line support guidewires or other devices in facilitating vascular access in the arterial system to enable various types of interventions. The company’s lead management product line comprises excimer laser sheaths, non-laser sheaths, and cardiac lead management accessories for the removal of pacemaker and defibrillator cardiac leads. It sells its products in the United States, Canada, Europe, the Middle East, the Asia Pacific, Latin America, and Puerto Rico. The company has strategic alliances with Kensey Nash Corporation and ELANA BV. The Spectranetics Corporation was founded in 1984 and is based in Colorado Springs, Colorado.

ACQUIRED

Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine.

The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2.0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability. In addition, it develops Augmented Reality and Artificial Intelligence digital surgery platform to enable digital spine surgery. The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois.

Syneron Medical Ltd., together with its subsidiaries, engages in the research, manufacture, development, marketing, and sale of aesthetic medical products under the Syneron and UltraShape brand names worldwide. The company develops products based on its proprietary Electro-Optical Synergy technology, which uses the synergy between electrical energy and optical energy to provide aesthetic medical treatments. Its products target a range of non- invasive aesthetic medical procedures, including hair removal, wrinkle reduction, rejuvenation of the skin’s appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, laser-assisted lipolysis, and topical skin brightening products.

Syneron Medical Ltd.also develops, manufactures, and markets non-invasive technologies for fat cell destruction and body sculpting; and Viador system, a handheld device with a radiofrequency-needle array for use in transdermal delivery of biologic drug-products via a system-specific skin patch. In addition, the company provides cosmetic and aesthetic lasers, and light-based systems used by physicians and personal care practitioners. The company sells its products to dermatologists, plastic and cosmetic surgeons, other qualified practitioners, and aestheticians and medical spas through direct sales force and distributors; and to home-use consumers directly. Syneron Medical Ltd. was founded in 2000 and is headquartered in Yokneam Illit, Israel.

ACQUIRED

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States. The company’s flagship product is the t:slim X2 insulin delivery system that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:flex insulin delivery system that includes t:flex pump, its 480-unit disposable insulin cartridge, and an infusion set; t:slim X2 with G5 integration; and Tandem Device Updater, a PC and Mac-compatible tool that allows users to update their pump’s software. In addition, the company offers t:connect diabetes management application, a cloud-based data management application, which provides a visual way to display therapy management data from the pump and supported blood glucose meters for users, their caregivers, and their healthcare providers; t:lock cartridge and infusion set products; and various pump accessories. Its products in development include automated insulin delivery systems; t:slim X2 with Basal IQ; t:slim X2 with control IQ; t:sport insulin delivery system; and connected (mobile) health mobile application. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was founded in 2006 and is headquartered in San Diego, California.

Universal Health Realty Income Trust, a real estate investment trust, invests in healthcare and human service related facilities including acute care hospitals, rehabilitation hospitals, sub-acute care facilities, medical/office buildings, free-standing emergency departments and childcare centers. We have investments in seventy-one properties located in twenty states, including two that are currently under construction.

Universal American Corp., a specialty health and life insurance holding company, provides health insurance and managed care products and services to the growing Medicare and Medicaid population in the United States. The company’s Senior Managed Care—Medicare Advantage segment offers Medicare coordinated care plans, including PPOs and HMOs; network-based private fee-for-service plans(PFFS) and rural PFFS; and Medicare covered benefits, as well as provides additional supplemental benefits, including a defined prescription drug benefit.

Universal American’s Traditional Insurance segment includes Medicare supplement and other senior health insurance products; specialty health insurance products, primarily fixed benefit accident and sickness insurance; term care, disability, medical, universal life, and fixed annuities; and senior life insurance products.

The company distributes its products through a network of channels comprising career agency and independent agents, as well as through telephonic and Internet enrollment. Universal American Corp. was founded in 1981 and is headquartered in White Plains, New York.

ACQUIRED

Veradigm Inc., a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm. The Hospitals and Large Physician Practices segment provides integrated clinical and financial management solutions, which primarily include EHR-related software; and related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Veradigm segment offers payer and life sciences solutions, which are primarily targeted at payers, life sciences companies, and other healthcare stakeholders; and software applications for patient engagement and EHR software to single-specialty, and small and mid-sized physician practices, including related clinical, financial, administrative, and operational solutions. Its solutions enable clients to transition, analyze, and coordinate care, and enhance the healthcare delivery across the care community. The company serves physicians, hospitals, governments and militaries, health systems, health plans, life-sciences companies, retail clinics, surgery centers, retail pharmacies, pharmacy benefit managers, insurance companies, employer wellness clinics, consumers, lab companies, urgent care facilities, and venture capital firms, as well as post-acute organizations, such as home health and hospice agencies. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Volcano Corporation designs, develops, manufactures, and commercializes a suite of precision guided therapy tools worldwide. The company operates in two segments, Medical and Industrial. It offers intravascular ultrasound (IVUS) and fractional flow reserve (FFR) products that enhance the diagnosis and treatment of coronary and peripheral vascular disease by enhancing the efficiency and efficacy of existing diagnostic angiograms and percutaneous coronary interventional and endovascular procedures in the coronary arteries or peripheral arteries and veins.

The company’s IVUS products include single-procedure disposable phased array and rotational IVUS imaging catheters; and ChromaFlo stent apposition analysis technology that uses sequential IVUS frames to differentiate circulating blood from stationary or anchored tissue. Its FFR products comprise pressure and flow consoles, and single-procedure disposable pressure and flow guide wires, which are used to measure the pressure and flow characteristics of blood around plaque enabling physicians to gauge the plaque’s physiological impact on blood flow and pressure.

In addition, the company offers adenosine-free Instant Wave-Free Ratio FFR; and SyncVision, which co-registers IVUS with angiography. Further, the company develops and manufactures optical monitors for the telecommunication industry; laser and non-laser light sources; optical engines used in the medical optical coherence topography imaging systems and advanced photonic components; and sub-systems used in spectroscopy and other industrial applications.

It sells its products through direct sales force and distributors, as well as through supply and distribution agreements with third parties. Volcano Corporation was founded in 2000 and is headquartered in San Diego, California.

ACQUIRED